Senior Vice President R&D, Regulatory and Scientific Affairs Bruker DALTONICS Microbiology & Diagnostics
BIOGRAPHY
SEP 15, 2021 9:00 AM PDT
The Market Leading MALDI Biotyper ® CA System: Past, Present and Future
Speaker
Event Date & Time
Date: September 15, 2021
Time: 9:00am (PDT), 12:00pm (EDT)
Abstract
Dr. Markus Kostrzewa will elaborate on the progress that has been made in Bruker Microbiology & Diagnostics, specifically on the innovation and evolution of the FDA-cleared MALDI Biotyper® CA System. The discussion will begin by presenting the evolution of the MALDI-TOF mass spectrometer and the key innovative changes since FDA-clearance in 2013. Dr. Kostrzewa will then discuss the latest expansion of the MALDI Biotyper CA System Reference Library followed by details in the development of the FDA-cleared MBT Sepsityper® Kit US IVD which provides a microbial ID direct from positive blood culture in less than 20 minutes for over 488 organisms. To conclude the presentation, Dr. Kostrzewa will briefly present Bruker's ongoing innovation projects and studies to further enhance technologies to address today’s critical diseases.
Learning Objectives
- Explain the advantages of MALDI-TOF technology over traditional microbiology techniques for microbial identification
- Discuss how rapid microbial ID testing direct from positive blood cultures can impact patient outcomes
- Discuss how the implementation of rapid microbial ID testing direct from positive blood cultures can positively impact the clinical institution
Only for sale in the USA and Puerto Rico.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...